Blackstone, Massachusetts; February 8, 2005 - Mossman Associates of Blackstone, Massachusetts, USA and Nanjing Potomac Biotechnology Co. Ltd of Nanjing City, People's Republic of China announced today that the Chinese government has approved Nanjing Potomac Bio-technology 's Protein Chip diagnostic kit for the identification of IgG antibody to Mycobacterium Tuberculosis.

Nanjing Potomac Biotechnology Co. Ltd. is a company focused on the development and manufacturer of Bio-Chips and Chip Scanner within China. They produce several protein chips as well as gene-chips for various purposes, all utilizing the same scanner plate-format for interpreting the results. This particular Bio-Chip test consists of incubating patient sample with antigen coated membrane and with the use of colloidal gold as a tag identifies TB infection when used in conjunction with the chip scanner. This is the first product in the form of a Bio- chip for TB detection approved by Chinese Government and is planned for use by the People's Republic of China's Disease Control Center, The Administration of Inspection and Quarantine, as well as hospitals.

Mossman Associates supplies reagents to manufacturers of diagnostic test kits, as well as manufactures medical diagnostic products of their own such as MycoDot™ a serological test for TB and NicCheckTM an FDA approved urine dipstick test for measuring nicotine. Both diagnostic test kits are in a rapid format and do not require instrumentation for the interpretation of results.

"We are glad to have contributed to another test for the accurate and affordable diagnosis of tuberculosis in humans. Our ability to provide antigen whether on a chip such as with the Potomac Biotechnology system, being read on an instrument , or a comb such as our MycoDotTM test being read by eye, is a major step in getting serological tests for TB into main steam use", notes Donald Mossman, President of Mossman Associates Inc..

For more information, please contact:

Blackstone, Massachusetts; 12/29/04 - Mossman Associates, Inc. announced today that with the approval form the Kosheio (Japan's FDA) and under the watchful eye of this governmental agency hundreds of thousands of MycoDot tests have been used in Japan.

MycoDot provides the Japanese the opportunity to diagnose TB within 20 minutes using a very small amount of serum or whole blood saving major amounts of time as well as establishing cost controls.

MycoDot continues to provide high sensitivity with excellent specificity with data on performance provided on the following web page.
http://www.ramcojapan.co.jp/product/Mycodot/deta.htm

Smoking Cessation Competition Uses NicCheck For Second Time.

Blackstone, Massachusetts; 10/15/04 - Mossman Associates, Inc. announced today that the International Quit&Win 2004, a smoking cessation competition taking place in some 100 countries world wide, has chosen NicCheck I for the second time to be the test used to confirm smoking cessation.

The program which takes place every 2 years is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH). Quit&Win is a "Practical Collaboration For Global Tobacco Cessation" and a cost-effective way to reduce smoking among the population.

The international experience shows that Quit&Win can easily be implemented in different populations and cultures. All contestants had smoked daily for at least one year and are 18 years of age or older. The contestants are required to abstain from smoking for at least four weeks, which is verified with a urine test among the winners. The test chosen for the second time is NicCheck.

Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit&Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years.

For more information visit. http://www.quitandwin.org/fi/content/sisallot/contact/03links?C:D=54583&C:selres=54583